# Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study

> **NCT00184496** · PHASE3 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 42 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Methadone

## Key facts

- **NCT ID:** NCT00184496
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184496, "Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00184496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*